
Please try another search
By Sam Boughedda
BofA Securities analyst Mariana Pérez Mora initiated coverage of Palantir Technologies (NYSE:PLTR) with a Buy rating and a $13 price target on Tuesday.
In a note to investors, the analyst said they see Palantir as a beneficiary of rapidly growing demand for AI platforms in both commercial and government end markets.
“Palantir’s dominant position in the AI-powered software market, differentiated end-to-end & highly-secure solutions and first-mover advantages should support more than 30% annual revenue expansion and improving profits in the midterm,” Mora explained.
In addition, Mora said “increased urgency on modernizing military and intelligence capabilities” will provide significant opportunities.
“Our PO is based on a long-term DCF of Base, Bull, and Bear cases for different revenue and cash generation scenarios between now and 2040,” wrote the analyst. “We think PLTR stock has not benefited from the recent defense re-rating despite significant US National Security exposure. While geopolitical tensions pose a risk to worldwide software penetration, they are an opportunity for Palantir’s national security solutions in the US and allied countries, as militaries and intel services will need enhanced data and logistics capabilities as soon as possible.”
BofA expects US and allies' defense budgets to grow with an increased focus on modernization and implementation of new technologies.
“Data is a strategic asset and national security agencies have to make sure they operationalize it securely to better defend from near peer threats like Russia or China.”
By Timothy Gardner SHEBOYGAN, Wisc. (Reuters) - Travel brochures in Sheboygan, Wisconsin, tout the town’s beaches on Lake Michigan as the Malibu of the Midwest. But pages of...
By Ambar Warrick Investing.com-- Elon Musk sold about $6.9 billion worth of Tesla Inc (NASDAQ:TSLA) stock over the past week, a filing revealed on Wednesday, as the Tesla CEO...
Highlights: Dual-listed a2 Milk Company has informed that its application to import baby milk formula to the US has been deferred by the US FDA. Earlier this month, a2MC had stated...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.